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Objective:  This study was to determine whether simultaneous antegrade-retrograde
cardioplegia through a single coronary artery and the coronary sinus provides suffi-
cient and homogeneous perfusion to the heart.
Methods:  Simultaneous antegrade-regrograde cardioplegia was conducted in 7 iso-
lated pig hearts through the coronary sinus in conjunction with the left anterior
descending artery, the left circumflex artery, and the right coronary artery, respective-
ly. The efficacy of simultaneous antegrade-retrograde cardioplegia for myocardial
perfusion was assessed by monitoring the distribution of magnetic resonance contrast
agent and measuring the effluent from the venting coronary arteries.
Results:  Injection of contrast agent into a perfusing artery during simultaneous ante-
grade-retrograde cardioplegia resulted in increased image signal intensity not only in
the territory of the perfusing artery but also in the areas normally served by the other
2 venting arteries (including the right ventricular wall). The myocardium in the terri-
tories of the 2 venting arteries was lightened with contrast agent given into the coro-
nary sinus during simultaneous antegrade-retrograde cardioplegia. Myocardium in the
perfusing artery territory and right ventricular wall remained dark. Moreover, a sig-
nificant amount of effluent was collected from the venting arteries during simultane-
ous antegrade-retrograde cardioplegia: 4.7 to 7.8 mL/min from the right coronary
artery; 10.5 to 17.7 mL/min from the left anterior descending artery; and 9.7 to 15.2
mL/min from the left circumflex coronary artery.
Conclusions:  Simultaneous antegrade-retrograde cardioplegia through a single coro-
nary artery and the coronary sinus provides homogeneous perfusion to the entire
heart. During simultaneous antegrade-retrograde cardioplegia, arterial flow supports
its own designated myocardium, as well as adjacent myocardium normally served by
the venting arteries; the arterial route also supports the right ventricular free wall when
the right coronary artery is vented. Venous perfusion of simultaneous antegrade-ret-
rograde cardioplegia mainly supports myocardium in the territories of the venting
arteries and does not perfuse the right ventricular free wall. Blood flow delivered to
myocardium normally supported by the venting arteries is believed to be sufficient to
prevent ischemic injury.
Antegrade and retrograde cardioplegia are often used for myocar-dial protection during cardiac surgery.1,2 In the presence of criti-cal coronary stenosis or occlusion, antegrade cardioplegia isunable to deliver a sufficient amount of cardioplegic solution tothe myocardium served by the diseased coronary arteries.3,4Because atherosclerosis does not occur in the coronary venous
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system, retrograde cardioplegia through various venous routes
has gained popularity in the operating room.5 Because of its
low flow rate, heterogeneous distribution, and poor protection
of the right ventricular wall, retrograde cardioplegia has been
shown to be less efficient than antegrade cardioplegia in pro-
tecting normal regions of the myocardium.6,7 A combination
of antegrade and retrograde cardioplegia has been proposed as
a better approach for protecting the diseased heart than using
antegrade or retrograde cardioplegia alone.8-10
Simultaneous antegrade-retrograde cardioplegia (SARC)
can be performed through the coronary sinus in conjunction
with either the aorta or the ostium of a coronary artery or a
completed vein graft. We have previously assessed the effica-
cy of SARC through the aorta and the coronary sinus on
myocardial perfusion in the jeopardized region.11 In that study
the left anterior descending artery (LAD) of the isolated pig
hearts was occluded to create a region of jeopardized
myocardium. It was found that both routes (aorta and coronary
sinus) of SARC delivered cardioplegic solution to the jeopar-
dized myocardium to sustain normal myocardial energy
homeostasis. The results demonstrated that SARC through the
aorta and the coronary sinus provides adequate protection to
the myocardium beyond a coronary occlusion.
However, it was unclear whether SARC provides homoge-
neous perfusion to all regions of the heart when performed
through a single coronary artery and the coronary sinus. The
present study was designed to answer this question. This car-
dioplegic technique is often used for deairing, as well as for
perfusion after completion of a coronary graft.12
Materials and Methods
Isolated Pig Heart Preparation
All animals used in this study received humane care in compliance with
the “Guide to the Care and Use of Experimental Animals” formulated
by the Canadian Council on Animal Care. The protocol for this study
was approved by the Animal Care Committee of the National Research
Council of Canada. The pig heart was chosen as the animal model
because it shares some similarities with the human heart.13,14
Seven domestic pigs weighing 45 to 50 kg were sedated by means of
intramuscular injection of atropine (0.06 mg/kg body weight), diazepam
(0.4 mg/kg body weight), and ketamine (20 mg/kg body weight).
Figure 1. Schematic illustration of experimental protocol.
Figure 2. Outflow rates measured at the venting arteries during AP
(upper panel) and during SARC (lower panel). Data are presented
as means ± standard deviation of the mean. CF, Coronary flow.
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Anesthesia was maintained with 1.5% to 2.0% isoflurane in a mixture
of oxygen and medical air. The rate and volume of positive-pressure
ventilation were adjusted to keep the arterial blood gases within the nor-
mal physiologic range. The brachiocephalic artery was cannulated at the
level of the common carotid artery for arterial pressure monitoring,
blood sampling, and injection of cardioplegic solution.
A sternotomy was performed, and the brachiocephalic and sub-
clavian arteries were dissected. A cannula for the infusion of cardio-
plegic solution was introduced into the ascending aorta from the bra-
chiocephalic artery. The pericardium was opened longitudinally
along the midline. The descending aorta was isolated at its origin for
crossclamping. The animal was then heparinized by injecting 3000
IU of heparin into the right atrium. Heparinized cold (approximately
4°C) cardioplegic solution was delivered into the aortic root (10
mL/kg body weight) to arrest the heart. The heart was then excised
from the animal. Blood in the chest of the pig was collected and
mixed in a 1:1 ratio with Krebs-Henseleit solution. The hemoglobin
concentrations in pig blood and the mixture were 9.6 ± 0.7 g/dL and
5.0 ± 0.1 g/dL, respectively. The mixture was oxygenated with 95%
oxygen and 5% carbon dioxide to a final pH and PO2 of 7.41 ± 0.02
and 545 ± 35 mm Hg, respectively.
The 3 major coronary arteries were cannulated separately at their
origins by using 0.085-inch diameter polyethylene cannula for deliv-
ery and drainage of blood cardioplegic solution and for washout of
contrast agent. A 15F retrograde cannula (DLP Inc, Grand Rapids,
Mich) with a manually inflated balloon at the tip was positioned
approximately 1 cm into the coronary sinus. The position of the
catheter was adjusted such that the external edge of the balloon was
at the orifice of the coronary sinus. If the anterior ascending cardiac
vein drained directly into the right atrium (bypassing the coronary
sinus), it was also cannulated for venous delivery during SARC. The
hemiazygos vein was ligated to facilitate venous delivery of cardio-
plegic solution during SARC. The heart was maintained at 36°C to
37°C throughout the experiment.
Experimental Protocol
Seven pig hearts were used in this study and were perfused with a
hyperkalemic (16 mmol/L KCl and 16 mmol/L MgCl2) mixture of
pig blood and Krebs-Henseleit solution. The hearts were first sub-
jected to antegrade perfusion (AP) through one of the 3 coronary
arteries. Two milliliters of gadolinium-diethylenetriamine penta-
acetic acid (Gd-DTPA) was injected as a bolus into a coronary artery
to define the artery-supported myocardium. The hearts were then
subjected to SARC through one coronary artery and the coronary
sinus. The coronary arteries not used to deliver cardioplegic solution
during SARC were vented to zero pressure for effluent collection and
Figure 3. Representative images obtained during AP through the 3 major coronary arteries with contrast agent
injected into the LCX (A), the LAD (B), and the RCA (C).
Figure 4. Representative MR images. A shows an image obtained during AP with Gd-DTPA injected into the RCA.
Images acquired during SARC with Gd-DTPA injected into the RCA and the coronary sinus are shown in B and
C, respectively.
A B C
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are referred to as the venting arteries. If cannulated, the anterior
ascending cardiac vein was also used for venous perfusion of SARC.
During SARC, 2 mL of Gd-DTPA was first injected into the arterial
catheter and then into the venous catheter (including the coronary
sinus). Between each injection of contrast agent, AP was carried out
for approximately 5 minutes through all 3 arterial catheters to wash
out the contrast agent and to resuscitate the heart. During SARC, per-
fusion pressures at both arterial and venous ends were maintained at
40 to 45 mm Hg. The distribution of contrast agent during AP and
SARC was assessed by using T1-weighted magnetic resonance (MR)
imaging. Complete washout of the contrast agent was ensured before
any further injection of contrast agent by observing complete return
of signal intensity to its baseline level. During SARC, the venting
arterial catheters were open to the atmosphere. The experimental pro-
tocol is illustrated schematically in Figure 1.
The rate of blood flow into the arterial and venous catheters and
the outflow at the venting arterial catheters were measured by using
transonic flowmeters and timed collection, respectively.
MR Perfusion Imaging
The effect of SARC on myocardial perfusion was assessed by using
T1-weighted MR imaging because of its high magnitude of signal
enhancement and low susceptibility artifact. MR imaging was per-
formed on a 7-T, 40-cm horizontal bore magnet equipped with a
Biospec console (Bruker Inc, Karlsruhe, Germany) and a Helmholtz
probe surrounding the whole heart. T1-weighted MR images were
acquired by using an inversion recovery Turbo-FLASH sequence
with a 3.6-ms echo time and a 6.4-ms repetition time. Each image
covered a 15 × 15 cm2 field of view with a 128 × 128 matrix, leading
to a pixel size of 1.25 × 1.25 mm2. All images were acquired from a
3-mm slice parallel to the short axis of the heart.
Data Analysis
MR images were analyzed with Evident (Institute for
Biodiagnostics, Winnipeg, Canada), a 2-dimensional/3-dimension-
al image-analysis software. Statistical analyses were performed
with Statistica software (Statsoft Inc, Tulsa, Okla). Comparison of
PO2 in effluents at different venting arteries was performed by
using the Student t test. This test was also used to compare the out-
flow rates from different venting arteries during SARC. All numer-
ic results are expressed as means ± standard deviation of the mean.
Results
Figure 2 shows the efflux rates at 2 venting arteries during AP
and SARC. As shown, very low efflux rates were observed at
Figure 5. Representative MR images. A shows an image obtained during AP with Gd-DTPA injected into the LAD.
Images acquired during SARC with Gd-DTPA injected into the LAD and the coronary sinus are shown in B and
C, respectively.
Figure 6. Representative MR images. A shows an image obtained during AP with Gd-DTPA injected into the LCX.
Images acquired during SARC with Gd-DTPA injected into the LCX and the coronary sinus are shown in B and C,
respectively.
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the 2 venting arteries when the heart was perfused antegrade-
ly through a single coronary artery. Only 0.8 ± 0.2 mL/min
and 0.6 ± 0.1 mL/min effluent were collected at the LAD and
left circumflex artery (LCX), respectively, when AP was per-
formed through the right coronary artery (RCA) at a flow rate
of 90 ± 6.0 mL/min. With an average flow rate of 155 ± 8
mL/min during AP through the LAD, the rates of outflow at
the RCA and LCX were 0.6 ± 0.2 mL/min and 0.7 ± 0.4
mL/min, respectively. When the LCX was used for AP at a
flow rate of 140 ± 10 mL/min, the rates of outflow were 0.5 ±
0.2 mL/min and 0.6 ± 0.3 mL/min at the LAD and RCA,
respectively. Different flow rates into the 3 arteries during AP
were intended to maintain a uniform pressure load. The low
rates of outflow from the venting arteries suggest that there is
no significant collateral circulation between the major coro-
nary arteries during AP. Figure 3 shows 3 representative
images acquired from the same pig heart during AP, with con-
trast agent given into one coronary artery at a time. As the
images show, each coronary artery supports its designated
region of the myocardium under AP, and there is no significant
overlap between each artery-supported region. This also indi-
cates there is no significant collateral flow during AP.
During SARC, the rates of outflow from the 2 venting
arteries increased significantly relative to those attainable with
AP (Figure 2, lower panel). When SARC was performed
through the RCA and the coronary sinus at a total flow of 170
± 14 mL/min, the rates of outflow from the LAD and LCX
were 10.5 ± 5.6 mL/min and 9.7 ± 3.6 mL/min, respectively.
The difference between the outflow rates from the 2 arteries
was not statistically significant (P = .6). When SARC was
delivered through the LAD and the coronary sinus at a total
flow of 195 ± 12 mL/min, the rates of outflow from the RCA
and LCX were 4.7 ± 2.1 mL/min and 15.2 ± 7.0 mL/min,
respectively. The difference in the outflow rates from the 2
venting arteries reaches a significant level (P = .002). The rates
of efflux from the LAD (17.7 ± 6.4 mL/min) and RCA (7.8 ±
4.7 mL/min) were also significantly different (P = .006) when
SARC was performed through the LCX and the coronary
sinus at a total flow of 200 ± 15 mL/min. The increased rates
of outflow from the venting arteries indicate that SARC deliv-
ered through a single coronary artery and the coronary sinus
helps perfuse the myocardium in the regions normally served
by the venting arteries. Different total flows were used for
each SARC modality to maintain perfusion pressure within
the 40 to 45 mm Hg range. In addition, the efflux rate from the
RCA was significantly (P = .000) lower than that from the
LAD and LCX during SARC.
The PO2 and the pH of the effluents collected from the 2
venting arteries during SARC are summarized in Table 1. The
PO2 in all the samples collected from the venting arteries dur-
ing SARC was higher than normal (40 mm Hg) for venous
blood collected at the coronary sinus under physiologic condi-
tions. This suggests that SARC delivered through a single
coronary artery and the coronary sinus provides sufficient flow
to the regions served by the 2 venting arteries. The effluent
rates at the venting arteries during AP were too low for reliable
measurement of blood gases, and thus no data are presented.
The distributions of cardioplegic solution during AP and
SARC are shown in Figures 4, 5, and 6. As mentioned above,
injection of Gd-DTPA into a coronary artery during AP result-
ed in increases in image intensity only in the territory served
by the perfusing artery (Figures 4, A, 5, A, and 6, A).
Myocardium supported by the venting arteries remained dark.
During SARC, injection of contrast agent into a coronary
artery resulted in an increase in image intensity not only in the
territory served by the perfusing artery but also in the areas
normally served by the 2 venting arteries (Figures 4, B, 5, B,
and 6, B). With contrast agent given into the LAD or LCX dur-
ing SARC, the right ventricular free wall always brightened.
The increase in signal intensity in the regions of the venting
arteries was significantly less than that observed in the region
supported by the perfusing artery (data not presented). The
total area of brightened myocardium in the territory of the
venting arteries varied from heart to heart. Nevertheless, the
increase in signal intensities in the areas served by the venting
arteries suggests that arterial perfusion of SARC contributes to
myocardial perfusion in the areas served by the venting arter-
ies. When contrast agent was injected into the coronary sinus
during SARC, image intensity increased only in the areas nor-
mally served by the venting arteries. The region supported by
the perfusing artery showed no increase in signal intensity.
Moreover, the right ventricular free wall remained dark, even
when the RCA was vented. The total area of contrast-
enhanced myocardium in the territory of the venting arteries
also varied from heart to heart. However, the sum of the
brightened areas observed during SARC with contrast agent
given into a coronary artery and the coronary sinus always
covered the entire area of the heart viewed along its short
axis. This suggests that SARC performed through a single
coronary artery and coronary sinus can provide homoge-
neous perfusion to the heart.
TABLE 1. PO2 and pH effluents at the 2 venting arteries dur-
ing SARC
Route of
SARC effluent PO2 P value pH
RCA + CS LAD 63 ± 11 .09 7.36 ± 0.02
LCX 48 ± 21 7.31 ± 0.08
LAD + CS LCX 68 ± 17 .046 7.33 ± 0.03
RCA 53 ± 6 7.36 ± 0.02
LCX + CS LAD 105 ± 18 .003 7.32 ± 0.01
RCA 58 ± 29 7.36 ± 0.02
Average PO2 and pH values of oxygenated cardioplegic solution were 545
± 35 mm Hg and 7.41, respectively.
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Discussion
It has been demonstrated that neither antegrade nor retrograde
cardioplegia provides adequate myocardial protection as a
result of inhomogeneous distribution of cardioplegic solution
in the presence of critical coronary stenosis. SARC through
the aorta and coronary sinus has been shown to preserve nor-
mal energy metabolism and prevent ischemic injury in jeop-
ardized areas of the myocardium. It is still unclear whether
this integrated approach supports the entire heart when SARC
is performed through a single coronary artery and the coro-
nary sinus. The latter modality of SARC is used more fre-
quently in clinical situations than that through the aorta and
coronary sinus. The present study shows that (1) SARC
through a single coronary artery and the coronary sinus deliv-
ers cardioplegic solution to all regions of heart; (2) the per-
fusing artery of SARC supports its own designated myocardi-
um, as well as myocardium normally served by the venting
arteries; and (3) the venous perfusion of SARC mainly sup-
ports myocardium in the territories served by the venting
arteries, except the right ventricular free wall.
As mentioned above, the efflux rates from the 2 venting
arteries during SARC ranged from 4.7 to 7.8 mL/min, 10.5 to
17.7 mL/min, and 9.7 to 15.2 mL/min in the RCA, LAD, and
LCX, respectively. By using the hemoglobin concentration
(5.12 ± 0.10 g/dL) and the partial pressure of oxygen (545 ±
35 mm Hg) in the delivered cardioplegic solution, it was esti-
mated that SARC provided approximately 0.43 mL/min, 0.98
mL/min, and 0.85 mL/min oxygen to the regions served by
the RCA, LAD, and LCX, respectively, when the normal sup-
porting arteries of these regions were vented. Under nor-
mothermic arrest conditions, the oxygen consumption rate of
the pig heart is around 6.7 µL · g–1 · min–1.15,16 Tissue
weights measured at the end of the experiments were 51 ± 5
g, 78 ± 6 g, and 53 ± 4 g in the regions supported by the RCA,
LAD, and LCX, respectively. Using the oxygen consumption
rate and tissue weight, oxygen demand was expected to be
approximately 0.34 mL/min, 0.52 mL/min, and 0.35 mL/min
in the RCA-supported, LAD-supported, and LCX-supported
myocardium, respectively. Oxygen demand of the RCA-sup-
ported myocardium approaches the amount supplied to the
region. In myocardium supported by the LAD and LCX, the
supply of oxygen appears to exceed demand. This suggests
that SARC can supply sufficient oxygen to the myocardium
in the territories of the venting arteries. Blood flow in the
region of the myocardium supported by a perfusing artery
during SARC far exceeds tissue demand.
It has been suggested that myocardial capillary flow does
not fully reflect effective nutrient flow or the oxygen delivery
capacity of venous perfusion.17-20 During venous perfusion,
exchange or diffusion may take place in the thin-walled
venous plexus, sinusoids, and thebesian system, as well as in
the capillaries.16,21,22 Blood from the former 3 systems may
drain directly into the heart chambers and not into the coro-
nary arteries.23-25 During SARC, myocardium normally sup-
ported by the venting arteries is believed to be perfused retro-
gradely because no significant arterial collateral vessels exist
in the pig heart. Therefore the actual nutrient flow (flow deliv-
ering oxygen to the myocytes) in the regions of venting arter-
ies may be much larger than the efflux rates measured at the
venting arteries. In addition, the cardioplegic solution used in
this study was more diluted (blood vs crystalloid in 1:1) than
that (4:1) used clinically. In clinical situations, the oxygen
delivery capacity of SARC in the regions served by venting
arteries is expected to be greater than that attainable in this
study.
Most of the venous blood from the right ventricular wall
drains directly into the heart chamber through the thebesian
vessels.23-25 This anatomic characteristic of the venous sys-
tem in the right ventricular wall explains why injection of
contrast agent into the coronary sinus during SARC did not
increase signal intensity in the right ventricular free wall.
However, when contrast agent was given into either the LAD
or LCX during SARC, signal intensity increased in the right
ventricle wall, as well as in myocardium supported by the
perfusing artery. The increase in signal intensity was smaller
in the right ventricular free wall than in the areas supported by
the LAD and LCX. We believe that this observation is the
result of extensive venous interconnections, which include
the venovenous collaterals and thebesian pathways.
With contrast agent given into the coronary sinus during
SARC, myocardium normally supported by the venting arter-
ies was illuminated. Myocardium in the territory of the per-
fusing artery remained dark. At present, it is unclear why the
coronary sinus route delivered cardioplegic solution only to
myocardium supported by the venting arteries and not to
myocardium supported by the perfusing artery under our
experimental conditions. Two factors may contribute to the
findings. First, during SARC, the hydraulic pressure gradient
between the coronary sinus and the capillaries (or coronary
arteries) is expected to be much greater in the areas support-
ed by venting artery than in those supported by the perfusing
artery because of the absence of perfusion in the former
regions. Conceivably, cardioplegic solution delivered through
the coronary sinus may flow more easily into the areas sup-
ported by the venting arteries than into those supported by the
perfusing artery. Second, we have found that the impedance
of the coronary venous system of the pig heart is approxi-
mately 5 times higher than that of the coronary artery system.
If only vascular impedance is taken into consideration, the
head pressure at the venous end during SARC may need to be
5 times greater than that at the arterial end to deliver cardio-
plegic solution to the same region of the myocardium from
both routes simultaneously. This explanation is oversimpli-
fied; however, it may suggest that the perfusion pressure at
the venous end should be significantly higher than that at the
arterial end to deliver cardioplegic solution to the same region
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of the myocardium through both routes simultaneously. In
this study the head pressures at the perfusing artery and the
coronary sinus were the same (40-45 mm Hg), which may
explain why SARC did not deliver cardioplegic solution to
myocardium supported by the perfusing arteries.
The present study was carried out on healthy young ani-
mals that had no significant arterial collateral vessels. In the
hearts of human patients, extensive arterial collateral circula-
tion usually develops after a long history of coronary disease.
Thus, it is expected that SARC through a single coronary
artery and the coronary sinus may provide more blood flow to
the venting artery–supported myocardium in patient hearts
than in normal pig hearts. In the current study the effect of
SARC on tissue perfusion was assessed in a single slice of the
heart. This slice was located between the apex and the atri-
oventricular sulcus. MR imaging results obtained from a sin-
gle slice may reflect myocardial perfusion in the whole heart,
but the finding should be extrapolated with caution to clinical
situations. In addition, because the blood pathway in the
myocardium supported by the venting arteries, particularly in
the ventricular septum and right ventricular free wall, is still
unclear, the nutritive efficacy of SARC in these regions of the
myocardium remains to be assessed. This can readily be done
by means of localized phosphorous 31 MR spectroscopy.
In summary, SARC through a single coronary artery and
the coronary sinus provides homogeneous perfusion to the
entire heart. During SARC, arterial perfusion supports its
own designated myocardium, as well as the adjacent
myocardium normally served by the venting arteries; the arte-
rial route also supports the right ventricular free wall when
the RCA is vented. Venous perfusion during SARC mainly
supports myocardium in the territories of the venting arteries
and not the right ventricular free wall. Blood flow delivered
to myocardium supported by the venting arteries is believed
to be sufficient to prevent ischemic injury.
We thank Mrs Lori Gregorash and Mr Allan Turner for their
assistance with animal preparation and heart perfusion.
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